GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
Popular glucagon-like peptide-1 (GLP-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference. Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers. The findings will be presented at the 2026 ASCO … Read more